Table 2.

Clinical laboratory data showing no difference between vaccinated and non-vaccinated patients.

Routine clinical lab data	All patients (n = 252)	Patients without vaccination (n = 97; 38%)	Patients already vaccinated before the first clinical presentation (n = 155; 62%)
Hematology and general
Hgb, g/dL	14.0 ± 1.3	13.9 ± 1.3	14.1 ± 1.3
Platelet, G/L	256 ± 55	258 ± 54	254 ± 56
Leukocyte, G/L	6.6 ± 1.8	6.6 ± 1.9	6.5 ± 1.7
Creatinin, mg/dL	0.78 ± 0.15	0.78 ± 0.17	0.77 ± 0.14
Albumin, g/L	47.5 ± 2.8	47.5 ± 2.7	47.5 ± 2.9
SGOT, U/L	24 ± 10	25 ± 12	24 ± 9
SGPT, U/L	28 ± 23	30 ± 25	27 ± 22
Eisen, ug/dL	92 ± 35.1	92.1 ± 38.8	91.9 ± 32.8
TSH, u/U/mL	1.58 ± 0.93	1.57 ± 0.8	1.59 ± 1
Coagulation
Prothrombin time, %	98.7 ± 18.4	97.2 ± 17.3	99.6 ± 19.1
INR	1.1 ± 0.2	1.0 ± 0.1	1.1 ± 0.2
aPTT, s	35.3 ± 4	35.7 ± 4.5	35.1 ± 3.7
Fibrinogen, mg/dL	312 ± 66.8	307 ± 68	315 ± 66
D-dimer, ug/mL	0 (0; 0.39)	0 (0; 0.35)	0.14 (0; 0.41)
Elevated D-dimer	18/223 (8.1%)a	6/88 (6.8%)	12/135 (8.9%)
vWF antigen, %	125 ± 53	129 ± 46	123 ± 57
ADAMTs13 activity, %	107 ± 27	108 ± 28	106 ± 26
Cardiology
Troponin T, ng/L	0 (0; 5)	0 (0; 5)	0 (0; 5.25)
Elevated troponin T	6/240 (2.5%)b	3/93 (3.2%)	3/149 (2.0%)
Creatine kinase, U/L	106 ± 66	103 ± 68	107 ± 65
NT-proBNP, pg/mL	45.4 (28.5; 85.1)	46.4 (26.3; 80.4)	45.4 (29.9; 92.8)
Elevated proBNP	15/243 (6.2%)c	5/92 (5.4%)	10/151 (6.6%)

Data are presented as mean ± SD, median (interquartile range), or number (frequency).

^aTwo patients were diagnosed with mild chronic obstructive pulmonary disease.

^bAcute coronary syndrome was excluded in all patients.

^cPatients were thoroughly evaluated for cardiac and pulmonary disease.